5 335
订阅者
+324 小时
+287 天
+9630 天
帖子存档
5 334
AGA Living Clinical Practice Guideline on Pharmacological
Management of Moderate-to-Severe Ulcerative Colitis 2024
5 334
AGA Living Clinical Practice Guideline on Pharmacological
Management of Moderate-to-Severe Ulcerative Colitis 2024
5 334
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease (MASLD)October 2024
5 334
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease (MASLD)October 2024
5 334
2024 EASL,Real-world experience with long-term albumin in patients with cirrhosis and ascites
5 334
2024 EASL,Real-world experience with long-term albumin in patients with cirrhosis and ascites
5 334
AGA Clinical Practice Update on Advances in Per-Oral
Endoscopic Myotomy (POEM) and Remaining Questions—
What We Have Learned in the Past Decade: Expert Review
5 334
AGA Clinical Practice Update on Advances in Per-Oral
Endoscopic Myotomy (POEM) and Remaining Questions—
What We Have Learned in the Past Decade: Expert Review
5 334
AGA Clinical Practice Update on Esophageal Dysfunction Due
to Disordered Immunity and Infection: Expert Review
5 334
AGA Clinical Practice Update on Esophageal Dysfunction Due
to Disordered Immunity and Infection: Expert Review
5 334
5 334
Spotlight: Pharmacological Management of
Moderate-to-Severe Ulcerative Colitis
